Joao Paulo Leonardo-Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joao Paulo Leonardo-Pinto has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Laguna Benetti-Pinto
University of Campinas, UNICAMP, Brazil, Brazil
2 shared publications - Daniela Angerame Yela
University of Campinas, UNICAMP, Brazil, Brazil
2 shared publications - Luiz Gustavo Oliveira Brito
Universidade Estadual de Campinas, Brazil
2 shared publications - Arissa Onishi
Universidade Estadual de Campinas, Brazil
1 shared publication - Carolina Neves Buhl
Universidade Estadual de Campinas
1 shared publication - Fernanda Rios Valvano1 shared publication
Latest Publications
- 13 May 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 48
Validation of the VALue of UteruS (VALUS) instrument in brazilian portuguese language for women with uterine fibroids and endometrial polyps: a cross-sectional study
- 13 May 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 48
Validation of the VALue of UteruS (VALUS) instrument in brazilian portuguese language for women with uterine fibroids and endometrial polyps: a cross-sectional study
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (7)
Prevalence of isthmocele according to diagnostic hysteroscopy, transvaginal ultrasound, and magnetic resonance imaging in non-pregnant women: cross-sectional study
SUMMARY OBJECTIVE: The aim of this study was to estimate the prevalence of isthmocele using transvaginal ultrasound, magnetic resonance imaging and diagnostic hysteroscopy. METHODS: A cross-sectional study conducted from 2020 to 2022 in tertiary academic hospital with ninety non-pregnant women with a history of cesarean section. Transvaginal ultrasound (n=90), magnetic resonance imaging (n=65) and office diagnostic hysteroscopy (n=81) were performed within a short interval for each patient. RESULTS: The women had a mean age of 34.8±6.3 years, mean number of 2.0±1.1 cesarean sections and mean duration of 40 months since their last cesarean. The prevalence of isthmocele with 95%CIs was 11.3% (5.5–19.7%) on transvaginal ultrasound, 66.1% (53.3–77.4%) on magnetic resonance imaging, and 43.2% (32.2–54.6%) on diagnostic hysteroscopy. When transvaginal ultrasound was considered reference, accuracy for diagnostic hysteroscopy was 57.89% (44.1%; 70.6%) and magnetic resonance imaging, 43.86% (30.9; 57.5%); when magnetic resonance imaging was reference, accuracy for diagnostic hysteroscopy was 54.39% (40.75; 67.43%). Agreement analysis (kappa) among the methods showed low scores between diagnostic hysteroscopy and magnetic resonance imaging regarding transvaginal ultrasound (0.126, p<0.001 and 0.103, p<0.001, respectively) and between diagnostic hysteroscopy and magnetic resonance imaging (0.206, p=0.014). CONCLUSION: The prevalence of isthmocele was lower in transvaginal ultrasound and higher in magnetic resonance imaging. Accuracy varied from 43 to 58% among the three methods and agreement between tests for diagnosing isthmocele was low.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (7)
Open AccessPrevalence of isthmocele according to diagnostic hysteroscopy, transvaginal ultrasound, and magnetic resonance imaging in non-pregnant women: cross-sectional study
SUMMARY OBJECTIVE: The aim of this study was to estimate the prevalence of isthmocele using transvaginal ultrasound, magnetic resonance imaging and diagnostic hysteroscopy. METHODS: A cross-sectional study conducted from 2020 to 2022 in tertiary academic hospital with ninety non-pregnant women with a history of cesarean section. Transvaginal ultrasound (n=90), magnetic resonance imaging (n=65) and office diagnostic hysteroscopy (n=81) were performed within a short interval for each patient. RESULTS: The women had a mean age of 34.8±6.3 years, mean number of 2.0±1.1 cesarean sections and mean duration of 40 months since their last cesarean. The prevalence of isthmocele with 95%CIs was 11.3% (5.5–19.7%) on transvaginal ultrasound, 66.1% (53.3–77.4%) on magnetic resonance imaging, and 43.2% (32.2–54.6%) on diagnostic hysteroscopy. When transvaginal ultrasound was considered reference, accuracy for diagnostic hysteroscopy was 57.89% (44.1%; 70.6%) and magnetic resonance imaging, 43.86% (30.9; 57.5%); when magnetic resonance imaging was reference, accuracy for diagnostic hysteroscopy was 54.39% (40.75; 67.43%). Agreement analysis (kappa) among the methods showed low scores between diagnostic hysteroscopy and magnetic resonance imaging regarding transvaginal ultrasound (0.126, p<0.001 and 0.103, p<0.001, respectively) and between diagnostic hysteroscopy and magnetic resonance imaging (0.206, p=0.014). CONCLUSION: The prevalence of isthmocele was lower in transvaginal ultrasound and higher in magnetic resonance imaging. Accuracy varied from 43 to 58% among the three methods and agreement between tests for diagnosing isthmocele was low.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (5) , e20260113
Evaluation of the use of dienogest in women with deep endometriosis and ovarian endometrioma: a retrospective cohort study
SUMMARY OBJECTIVE: The aim of this study was to evaluate the use of dienogest in the treatment of deep endometriosis and ovarian endometrioma. METHODS: This retrospective cohort study included 59 women diagnosed with ovarian endometrioma at a tertiary hospital between 2013 and 2018. Pain scores and endometrioma size were evaluated after 12 months of dienogest use, along with the women's sociodemographic characteristics. RESULTS: The mean age of the participants was 35.7±6.9 years. Unilateral endometrioma was observed in 38.9% of cases. There was a significant reduction in dysmenorrhea (p=0.011) with dienogest use, but no reduction in other pain symptoms. A reduction in left ovarian volume (p=0.009), mean left endometrioma size (p=0.01), and lesion size in the anterior cul-de-sac (p=0.047) was observed after dienogest treatment. A positive correlation was found between dyschezia and lesions in the posterior cul-de-sac before initiation of dienogest treatment. CONCLUSION: Dienogest appears to reduce pain in women with deep endometriosis. Our findings support dienogest as an effective therapeutic option.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (5) , e20260113
Open AccessEvaluation of the use of dienogest in women with deep endometriosis and ovarian endometrioma: a retrospective cohort study
SUMMARY OBJECTIVE: The aim of this study was to evaluate the use of dienogest in the treatment of deep endometriosis and ovarian endometrioma. METHODS: This retrospective cohort study included 59 women diagnosed with ovarian endometrioma at a tertiary hospital between 2013 and 2018. Pain scores and endometrioma size were evaluated after 12 months of dienogest use, along with the women's sociodemographic characteristics. RESULTS: The mean age of the participants was 35.7±6.9 years. Unilateral endometrioma was observed in 38.9% of cases. There was a significant reduction in dysmenorrhea (p=0.011) with dienogest use, but no reduction in other pain symptoms. A reduction in left ovarian volume (p=0.009), mean left endometrioma size (p=0.01), and lesion size in the anterior cul-de-sac (p=0.047) was observed after dienogest treatment. A positive correlation was found between dyschezia and lesions in the posterior cul-de-sac before initiation of dienogest treatment. CONCLUSION: Dienogest appears to reduce pain in women with deep endometriosis. Our findings support dienogest as an effective therapeutic option.